1 Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015. Ca Can J Clin,2016,66:115-132. 2 Mo W,Tong C,Zhang Y,et al.MicroRNAs′ differential regulations mediate the progress of human papillomavirus(HPV)-induced cervical intraepithelial neoplasia (CIN).BMC Syst Biol,2015,9:4-7. 3 桑菲,李佳蕊.微小RNA在卵巢癌中侵袭转移机制的研究进展.国际妇产科学杂志,2018,45:76-79. 4 Huang J,Peng J,Guo L.Non-Coding RNA:a new tool for the diagnosis,prognosis,and therapy of small cell lung cancer.J Thorac Oncol,2015,10:28-37. 5 Greither T,Grochola F,Cdelnow A,et al.Elevated expression of microRNAs 155,203,210 and 222 in pancreatic tumors is associated with poorer survival.Int J Cancer,2010,126:73-80. 6 Qiu S,Sheng L,Dan H,et al.Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients.J Trans Med,2013,11:10. 7 Wang X,Lu X,Zhang T,et al.mir-329 restricts tumor growth by targeting grb2 in pancreatic cancer.Oncotarget,2016,7:21441-21453. 8 Yang H,Li Q,Zhao W,et al.miR-329 suppresses the growth and motility ofneuroblastoma by targeting KDM1A.FEBS Lett,2014,588:192. 9 Li W,Liang J,Zhang Z,et al.MicroRNA-329-3p targets MAPK1 to suppress cell proliferation,migration and invasion in cervical cancer.Oncol Rep,2017,37:2743. 10 Tie J,Desai J.Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system.Crit Rev Oncog,2012,17:51-67. 11 Yan H,Jiang AT,Zhuang XJ,et al.CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis.Blood,2012,120:2330. 12 Flores-Nascimento MC,Alessio AM.CD144,CD146 and VEGFR-2 properly identify circulating endothelial cell.Rev Bras Hematol Hemoter,2015,37:98-102. 13 Robert J.Expression of VEGF VEGF-C and VEGFR-2 in in situ and invasive SCC of cervix.Front in Biosci,2010,E2:411-423. 14 Cheng H.Inhibiting CD146 by its Monoclonal Antibody AA98 Improves Radiosensitivity of Cervical Cancer Cells.Med Sci Monit Int Med J Exp Clinl Res,2016,22:3328-3333. 15 Wang P,Luo Y,Duan H,et al.MicroRNA 329 Suppresses Angiogenesis by Targeting CD146. Mol Cell Biol,2013,33:3689-3699. 16 Piscuoglio S,Burke KA,Ng CK,et al.Uterine adenosarcomas are mesenchymal neoplasms.J Pathol,2016,238:381-388. 17 龙玲,周琦,张笠.p38MAPK信号传导通路与卵巢癌关系研究进展.国际妇产科学杂志,2017,44:494-498. 18 Xu M,Li J,Wang X,et al.MiR-22 suppresses epithelial-mesenchymal transition in bladder cancer by inhibiting Snail and MAPK1/Slug/vimentin feedback loop.Cell Death Dis,2018,9:209. 19 Li XW,Tuergan M,Abulizi G.Expression of MAPK1 in cervical cancer and effect of MAPK1 gene silencing on epithelial-mesenchymal transition,invasion and metastasis.Asian Pac J of Trop Med,2015,8:915-921. 20 Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012. Ca A Cancer J Clin,2015,65:87-108. 21 Masaru W,Shingo K,Hiroki K,et al.The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy.Bmc Cancer,2016,16:1-7. 22 Yoshizawa E,Koiwai K,Ina H,et al.Outcomes of uterine cervical cancer patients with pelvic lymph node metastases after radiotherapy without boost irradiation of metastases.J Obs Gyn Res,2017,43:718. 23 Fang H,Shuang D,Yi Z,et al.Up-regulated microRNA-155 expression is associated with poor prognosis in cervical cancer patients.Biomed Pharmacother,2016,83:64-69. 24 Zhang YX,Qin LL,Yang SY.Down-regulation of miR-664 in cervical cancer is associated with lower overall survival.Eur Rev Med Pharmacol Sci,2016,20:1740-1744. 25 Chang YH,Yin F,Fan GF,et al.Down-regulation of miR-329-3p is associated with worse prognosis in patients with cervical cancer.Eur Rev Med Pharmacol Sci,2017,21:4045-4049.
